Position in ROIV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$283,860,641
+$57,661,140 QoQ
Shares Held
8,020,928
-1.8% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
43.97%
of 13F equity value
Holder Rank
#16
of 489 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Patient Square Capital LP holds $625,411,079 across 22 Biotechnology names. ROIV ranks #1 (45.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
8,020,928 | $283,860,641 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
276,000 | $51,689,280 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
260,500 | $30,496,735 | |
| 4 | ABVX |
Abivax S.A.
|
206,500 | $27,518,190 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
90,020 | $25,652,999 | |
| 6 | PHVS |
Pharvaris N.V.
|
671,209 | $23,210,407 | |
| 7 | ARGX |
Argenx SE
|
23,000 | $21,338,710 | |
| 8 | BLTE |
Belite Bio, Inc
|
110,000 | $16,938,350 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,860,641 | 8,020,928 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $226,199,501 | 8,166,047 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $177,203,219 | 8,166,047 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $188,822,400 | 12,480,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $140,649,600 | 12,480,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $125,923,200 | 12,480,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $147,638,400 | 12,480,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $141,116,486 | 12,228,465 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $129,254,875 | 12,228,465 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $128,888,021 | 12,228,465 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $141,946,301 | 12,639,920 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $147,634,265 | 12,639,920 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $127,410,393 | 12,639,920 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $50,375,636 | 6,825,967 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $54,539,476 | 6,825,967 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||